Integer Holdings Co. (NYSE:ITGR - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $137.29.
Several brokerages have issued reports on ITGR. Citigroup upped their price target on shares of Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a report on Tuesday, October 1st. Bank of America upped their price objective on shares of Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research note on Tuesday, October 1st. Oppenheimer started coverage on shares of Integer in a research note on Tuesday, July 16th. They set an "outperform" rating and a $135.00 price objective on the stock. Truist Financial upped their price target on shares of Integer from $137.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday, October 1st. Finally, Benchmark reaffirmed a "buy" rating and set a $130.00 price target on shares of Integer in a research report on Wednesday, October 2nd.
View Our Latest Analysis on Integer
In other Integer news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now directly owns 2,280 shares in the company, valued at $272,824.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 2.00% of the company's stock.
A number of large investors have recently added to or reduced their stakes in the stock. Contravisory Investment Management Inc. lifted its position in shares of Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after buying an additional 80 shares during the last quarter. Quest Partners LLC increased its holdings in shares of Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 332 shares during the period. GAMMA Investing LLC increased its holdings in shares of Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock worth $43,000 after acquiring an additional 142 shares during the period. Headlands Technologies LLC acquired a new stake in shares of Integer in the 1st quarter worth about $106,000. Finally, Innealta Capital LLC acquired a new stake in shares of Integer in the 2nd quarter worth about $110,000. 99.29% of the stock is currently owned by institutional investors.
Shares of ITGR opened at $129.24 on Friday. Integer has a 1-year low of $69.40 and a 1-year high of $131.87. The stock has a market cap of $4.33 billion, a PE ratio of 44.72, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a fifty day moving average price of $125.02 and a 200 day moving average price of $120.03.
Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating analysts' consensus estimates of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The company had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same period in the previous year, the business posted $1.14 earnings per share. Integer's quarterly revenue was up 9.0% on a year-over-year basis. As a group, sell-side analysts anticipate that Integer will post 5.3 EPS for the current year.
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.